Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
724studies shown
Showing 176-200 of 724
RecruitingNCT07309172

KetoBrain: Brain Energy Metabolism in Schizophrenia

This observational study is following people with Schizophrenia Disorder to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
Denmark
Sponsor
Ole Köhler-Forsberg
Condition
Schizophrenia
RecruitingNCT07176468

Personalized iTBS in Real-World Clinical Settings for Schizophrenia

This study is comparing Neuronavigation-guided individualized iTBS with Control group: ordinary drug treatment for people with Schizophrenia or Transcranial Magnetic Stimulation. Participants receive Neuronavigation-guided individualized iTBS or Control group: ordinary drug treatment and complete study visits and assessments.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
China
Sponsor
Anhui Medical University
Condition
Schizophrenia
RecruitingNCT06502964

Study of ALTO-101 in Patients With Schizophrenia

This study is looking at care and outcomes for people with Schizophrenia or Cognitive Impairment. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 21 Years to 55 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Schizophrenia
RecruitingNCT07061288

A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia

This study is looking at evaluate the dose levels, safety, and drug levels of KarXT intramuscular injection in participants with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
RecruitingNCT05838573

Metformin Treatment on Cognitive Impairment of Schizophrenia

This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
China
Sponsor
Central South University
Condition
Schizophrenia
RecruitingNCT07060066

Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia

This study is looking at provide an effective repetitive transcranial magnetic stimulation (rTMS) treatment for depressive symptoms in patients with schizophrenia for people with Schizophrenia and Related Disorders. Some participants may receive Sham rTMS stimulation instead of the study treatment, and direct benefit is not guaranteed.

DepressionOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Depression
RecruitingNCT06640803

Sacramento Clinical High Risk for Psychosis Stepped-Care Program

This study is looking at whether cognitive behavioural therapy can help people with Clinical High Risk for Psychosis or Ultra High Risk for Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

SchizophreniaOtherFrom 12 Years to 25 Years
Countries
United States
Sponsor
University of California, Davis
Condition
Schizophrenia
RecruitingNCT07003529

Role of Inferior Colliculi in Auditory Hallucinations

This study is looking at care and outcomes for people with Schizophrenia or Hallucinations, Auditory. Some participants may receive Control Group (SCZ+/AH-) instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Condition
Schizophrenia
RecruitingNCT06597864

Seven-step Phenomenological Psychotherapy for Self-disorder - a Pilot Study

This study is looking at whether psychoeducation can help people with Psychosis or Schizophrenic. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

SchizophreniaOtherFrom 18 Years to 39 Years
Countries
Norway
Sponsor
Oslo University Hospital
Condition
Schizophrenia
RecruitingNCT06642675

nTMS for Negative Symptom in Schizophrenia

This study is comparing Intermittent theta burst stimulation(iTBS) with control group: sham iTBS for people with Schizophrenia. Participants receive Intermittent theta burst stimulation(iTBS) or control group: sham iTBS and complete study visits and assessments.

SchizophreniaOtherUp to 60 Years
Countries
China
Sponsor
Central South University
Condition
Schizophrenia
RecruitingNCT06581302

Magnetic Seizure Therapy for Psychotic Disorders

This study is looking at whether Magnetic seizure therapy by Magnetic stimulator can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
China
Sponsor
Shanghai Jiao Tong University School of Medicine
Condition
Schizophrenia
RecruitingNCT07196423

Early Psychosis: Investigating Cognition

This study is looking at whether a digital support tool can help people with First Episode Psychosis or Psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
University of Nottingham
Condition
Schizophrenia
RecruitingNCT07234708

Feeling Safe Study

This study is looking at whether Sentirnos Seguros can help people with Schizophrenia and Schizophrenia Spectrum Psychosis. Participants take part in Sentirnos Seguros and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Condition
Schizophrenia
RecruitingNCT06634641

Clozapine-related Immunodeficiency in Parkinsons Disease

This study is looking at whether blood test can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire, Amiens
Condition
Schizophrenia
Schizophrenia | Clinical Trials | HopeStage Research